Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism. - Guerra P; Villano G; Rejano-Gordillo CM; Gil-Pitarch C; Ruvoletto M; Biasiolo A; Quarta S; Zapata-Pavas LE; Peña-SanFelix P; González-Recio I; Goikoetxea-Usandizaga N; Barrenechea-Barrenechea JA; et al. (British journal of cancer, 2026)